Workflow
多元醇
icon
Search documents
鲁西集团:锚定一流 破局向新   
Zhong Guo Hua Gong Bao· 2025-12-31 06:31
黄河与京杭大运河交汇处,孕育出一颗"两河明珠",这便是山东聊城。这座因河而生、枕水而居的城市,促进了 南北文化融合,也将中国与世界紧密相联。在聊城这片生生不息的土地上,同样有一颗石油和化工行业的"明 珠"——从1976年诞生时的万吨级小氮肥企业,一步步成长为如今的现代化、国际化、综合性化工企业,这便是鲁 西集团。 "十四五"时期,面对百年变局加速演进、全球产业链重构、"双碳"目标纵深推进等多重挑战,鲁西集团锚定"国内 领先、国际一流"目标,深化国企改革,强化创新驱动,推动高质量发展,实现了从传统化工向高端新材料产业进 军的成功跨越。五载砥砺,鲁西集团在科技创新、绿色转型、项目建设、管理跃升等各个战场斩关夺隘,取得历 史性突破,为"十五五"的壮阔航程再次鼓起风帆。 鲁西集团化工新材料产业园 向高端谋转型 产业蓝海奋楫争先 昔日的鲁西,曾凭借单一氮肥产品勇夺全国化肥产销量第一的桂冠,谱写了"全国化肥看山东,山东化肥看鲁 西"的行业传奇。然而,他们未曾沉溺于既往的"金山"。站在时代的十字路口,鲁西集团以"舟至中流,奋楫者 先"的魄力,从最熟悉的煤化工、盐化工领域起锚,迈开了向高端化工进军的历史性步伐。 "十四五"期 ...
化工ETF(159870)上涨1%,机构称化工白马中游环节产品已处于行业盈利底部区间
Xin Lang Cai Jing· 2025-12-26 02:13
华鲁恒升有机胺、肥料、醋酸、新能源新材料,2025Q1-3产量相比2020Q1-3增长45%/109%/161%/57% (新能源新材料因口径调整同比时间基数选择2022Q1-3)。公司本部通过技改有望实现盈利明显提 升,同步进行新能源新材料领域扩产。50%价差分位盈利在50亿元。 鲁西化工己内酰胺、尼龙6、甲酸、多元醇,2024年产量相比2020年增长55%/81%/44%/10%,并新增了 有机硅22.5万吨/年产能。50%价差分位盈利在39亿元。 龙佰集团钛白粉、钛精矿,2025H1产量相比2020H1增长68%/58%,海绵钛产能从1万吨/年扩增至8万吨/ 年,两矿合并正在快速推进,钛精矿产能将从140万吨/年提升至248万吨/年,铁精矿从400万吨/年提升 至760万吨/年,同时正在并购Venator英国15万吨/年氯化法钛白粉工厂。50%价差分位盈利在45亿元(考 虑两矿合并在64亿元)。 博源化工纯碱、小苏打、尿素,2025H1产量相比2020H1增长388%/59%/-1%,阿拉善二期280万吨/年纯 碱项目逐步投产,26年贡献增量。50%价差分位盈利在53亿元。 华峰化学氨纶、己二酸、聚氨酯 ...
华昌化工:多元醇项目预计12月底实现稳产
Zheng Quan Ri Bao Wang· 2025-12-16 14:10
证券日报网讯12月16日,华昌化工(002274)在互动平台回答投资者提问时表示,公司多元醇项目正在 进行试生产,预计12月底能实现稳产。 ...
华昌化工:氨合成装置技改项目正在做试生产准备,预计近期进入试生产状态
Mei Ri Jing Ji Xin Wen· 2025-12-16 08:37
(文章来源:每日经济新闻) 每经AI快讯,有投资者在投资者互动平台提问:30万吨多元醇项目是否已装料试生产?氨合成装置技 改和尿素技改分别什么时间完成并投入使用? 华昌化工(002274.SZ)12月16日在投资者互动平台表示,公司多元醇项目正在进行试生产,预计12月 底能实现稳产。氨合成装置技改项目正在做试生产准备,预计近期进入试生产状态。尿素技改项目正在 建没中。 ...
华昌化工(002274.SZ):公司多元醇项目正在进行试生产,预计12月底能实现稳产
Ge Long Hui· 2025-12-16 08:26
格隆汇12月16日丨华昌化工(002274.SZ)在互动平台表示,公司多元醇项目正在进行试生产,预计12月 底能实现稳产。 ...
减产30%引爆股价!有机硅巨头操盘“反内卷”将扭转行业颓势?
Quan Jing Wang· 2025-11-20 12:55
Group 1 - The core reason for the recent strength in the silicone industry is the joint production cut of 30% by leading companies like Luxi Chemical, leading to a rapid increase in spot prices by approximately 2000 yuan/ton within a few days, igniting market sentiment [1] - The policy environment is supportive, with ongoing measures to reduce overcapacity and promote supply-side reforms, including potential production limits and subsidies, which are expected to be discussed in upcoming industry meetings [1] - Demand for silicone products remains strong across multiple sectors, including photovoltaics, new energy, and healthcare, with the 14th Five-Year Plan designating silicone as a key new material, further enhancing the sector's valuation [1] Group 2 - Luxi Chemical's main products include various chemicals, but it does not produce vinyl carbonate (VC) [3] - Silica Technology's silicone materials are widely used in aerospace and military applications, although current sales are minimal and do not significantly impact overall performance [4] - Jinyin Galaxy is a leading manufacturer of silicone compound equipment in China, focusing on technological innovation and product upgrades to meet market demands, particularly in humanoid robotics [6] - Taili Technology has developed its own silicone pressure-sensitive adhesive, which has successfully entered the IKEA supply chain, indicating a focus on innovative applications [8] - Hengxing Technology's silicone products are suitable for manufacturing robot skin, with significant potential for future market expansion in robotics [10] - Times New Material's products are already applied in the energy storage sector, with ongoing orders from leading industry players [12] - Sanyou Chemical is facing challenges due to industry overcapacity and is implementing strategies to reduce production costs and enhance product value [14] - Hesheng Silicon's production capacity for industrial silicon and silicone monomers is significant, with production data to be released in upcoming reports [16] - China Chemical is actively developing in the silicon-based new materials sector, focusing on aerogel projects and optimizing multi-crystalline silicon technology to reduce energy consumption and investment [17]
鲁西化工(000830.SZ):未涉及磷酸铁锂
Ge Long Hui· 2025-11-19 07:57
Core Viewpoint - The company, Lu Xi Chemical (000830.SZ), clarified that its main products do not include lithium iron phosphate, focusing instead on a diverse range of chemical products [1] Product Overview - The company's primary products include: - Polyols - Caprolactam - Nylon 6 - Organosilicon - Formic acid - Methyl chloride - Methylamine - DMF (Dimethylformamide) - Polycarbonate [1]
鲁西化工(000830.SZ):未涉及VC
Ge Long Hui· 2025-11-19 07:31
Core Viewpoint - The company primarily produces a range of chemical products including polyols, caprolactam, nylon 6, organosilicon, formic acid, methylene chloride, methylamine, DMF, and polycarbonate, but does not engage in the production of VC (vinyl carbonate) [1] Product Overview - The main products of the company include: - Polyols - Caprolactam - Nylon 6 - Organosilicon - Formic acid - Methylene chloride - Methylamine - DMF - Polycarbonate - The company explicitly states that it does not involve VC (vinyl carbonate) in its product offerings [1]
鲁西化工:公司主要产品未涉及VC(碳酸亚乙烯酯)
Mei Ri Jing Ji Xin Wen· 2025-11-19 03:44
Core Viewpoint - The company, Lu Xi Chemical (000830.SZ), confirmed that it does not produce Vinyl Carbonate (VC) and focuses on other chemical products [1] Product Offering - The main products of the company include polyols, caprolactam, nylon 6, organosilicon, formic acid, methylene chloride, methylamine, DMF, and polycarbonate [1]
调研速递|鲁西化工2025年三季度业绩说明会召开 全体投资者参与 解读净利润下滑、应收账款等焦点问题
Xin Lang Cai Jing· 2025-11-17 09:20
Core Viewpoint - The company held a performance briefing for Q3 2025, addressing investor concerns regarding financial performance and business development through an interactive online format [1][2]. Financial Performance - The company's net profit for the first three quarters of 2025 decreased year-on-year, despite an increase in production and sales volume, due to a decline in chemical product prices that outpaced the decrease in raw material costs [3]. - R&D expenses fell by 18.93% year-on-year, attributed to differences in project timelines and content, but the company emphasized its commitment to increasing R&D investment [4]. Accounts Receivable - Accounts receivable surged by 154.47% compared to the beginning of the year, raising concerns about bad debt risk; however, the company stated that the accounts receivable balance accounted for only 0.53% of revenue, indicating a low overall risk [3]. Export Business - The company has established a global export presence, with products like formic acid and dichloromethane ranking among the top in national export volumes; plans to strengthen the foreign trade team and expand overseas markets were discussed [3]. Cash Flow and Market Management - The company maintains a solid cash flow and a good asset-liability ratio, with an AAA credit rating, ensuring sufficient funds for operational needs; it follows a prudent sales strategy of cash before delivery [4]. - The company is focused on long-term stable development and actively engages with shareholders through various channels, including investor hotlines and performance briefings [4]. Supply Chain Concerns - The company noted that the impact of recent international trade tariff uncertainties on its supply chain is minimal, as the proportion of import-export business is relatively low, and efforts are being made to build a secure domestic supply chain [4].